Compare Interlace Medical vs Micrus Endovascular
Customers evaluate the quality of Interlace Medical's products using the following success metrics.
Overview
Interlace Medical is 19 yrs old and is based in United States.
Interlace Medical Corporation designs and develops minimally invasive devices for the gynecological surgeon to aid them in removal of uterine fibroids and polyps.
Micrus Endovascular is 28 yrs old and is based in United States.
Micrus Endovascular develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus is developing products for the treatment of hemorrhagic and ischemic stroke. Both hemorrhagic and ischemic stroke are significant causes of death worldwide. Micrus product lines consist of endovascular systems that enable a physician to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus also sells accessory devices and products used in neurovascular procedures.
Demo Video
Leadership
Sarah O Kalil (Chief Operating Officer)
Eckhard H Reitz (Executive Vice President)
Investors
Hologic, New Leaf Venture Partners
Johnson & Johnson, Aventic Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Interlace Medical has not claimed their profile.
Work for Interlace Medical? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Interlace Medical?
Claim your profile now.
Information not available because Micrus Endovascular has not claimed their profile.
Work for Micrus Endovascular? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Micrus Endovascular?
Claim your profile now.